foxo4-dri senolytic peptide study 2017 cell regulates endothelial senescence via the P53 signaling pathway Molecular modelling of the FOXO4-TP53
Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21




